- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Parkinson disease
- Meeting Date: March 2024
- Public Summary Document (PSD) March 2024 PBAC Meeting - (PDF 1.3MB)
- Public Summary Document (PSD) March 2024 PBAC Meeting - (Word 690KB)
Levodopa with carbidopa and entacapone – March 2024
Levodopa with Carbidopa and Entacapone: Intestinal gel containing levodopa 20 mg with carbidopa monohydrate 5 mg and with entacapone 20 mg per mL, 47 mL; Lecigon®
Last updated
30 May 2025